Neonatal sepsis is a frequent cause of neonatal mortality; unfortunately, the symptoms of sepsis are not specific and may be attributed to other, noninfectious, causes. It is, therefore, crucial to pay attention to the risk factors for neonatal sepsis.

For early-onset infections, the maternal status of colonization by microorganisms and associated factors are the most important predictors of sepsis in neonates. Infection by group B streptococcus (GBS) species is the most frequent cause of neonatal sepsis, although the prophylactic antibiotic administration has decreased its incidence. Escherichia coli is another common cause of early-onset infections, followed in frequency by other organisms, such as haemophilus influenzae. Organisms such as GBS can invade the amniotic fluid during labor or through occult tears, and cause chorioamnionitis. Women with premature rupture of membranes are also at high risk for colonization of the amniotic fluid, as are those who have preterm labor. All of the above factors can suggest risk for sepsis in the newborn [1] [2]. In one study, women in preterm labor and with premature rupture of membranes were found to have a 75% incidence of microbial invasion of the amniotic cavity [3].

The most important risk factor for late-onset sepsis is the gestational age at delivery: premature newborns are at increased risk because of a weak immune system, or procedures utilizing invasive devices. The most common agent of late-onset sepsis is the group of coagulase-negative staphylococci, major nosocomial pathogens.

Initial signs of neonatal sepsis include decreased activity, feeding and breathing difficulties, abnormal temperature (too high or too low), and diarrhea or vomiting. Hypoglycemia, hyperglycemia, and metabolic acidosis often accompany sepsis, but also occur in purely metabolic conditions. Pneumonia, whether of intrauterine or intrapartum origin, may not be easy to differentiate from respiratory distress syndrome. Coughing, irregular respiration, decreased breath sounds and other symptoms characterize both diseases. Neurological signs (changes in consciousness, seizures, and others) are characteristic of meningitis, which is the common form of central nervous system infection in neonatal sepsis.

Early diagnosis is critical for starting therapy. The pathogen should be identified as soon as possible, so that the treatment with broad-spectrum antibiotics, which carries potential risks if continued too long, can be replaced by a regimen using more specific agents. Analysis of the complete blood cell count with differentials, together with cultures of blood, cerebrospinal fluid and urine (the latter only for late-onset sepsis) are performed in suspected cases.

Thrombocytopenia [4] and neutropenia [5] are frequently observed but are not specific signs. The immature to total neutrophil ratio is a more sensitive indicator of sepsis [5]. Sepsis screening panels use a variety of indicators, including leukocyte counts, neutrophil counts and immature to total neutrophil ratios [6]; their positive predictive value is highly diagnostic.

Blood cultures should test for both aerobic and anaerobic bacteria; growth usually occurs within two days. Results from tests using the polymerase chain reaction (PCR) are available in five hours [7]. Testing for herpes simplex virus is also done by PCR in cases where there is a strong indication of infection by the virus.

Of the acute phase proteins, C-reactive protein and procalcitonin have been used most extensively [8] [9]. A raised procalcitonin level 24 hours after birth is a good indicator of sepsis [10].

Analysis of the cerebrospinal fluid shows increased protein concentration and white blood cell count and decreased glucose concentration in case of meningitis. Cerebrospinal fluid culture should be obtained in cases of suspected sepsis if lumbar puncture can be performed. If the culture shows bacterial growth, further samples should be taken to follow the course of the disease and the effectiveness of treatment.

Chest radiography and imaging of the head by computed tomographic scan, magnetic resonance imaging, or ultrasonography are performed as needed.

The primary treatment for neonatal sepsis is the administration of broad-spectrum antibiotics, which are started as soon as sepsis is suspected. The choice of antibiotics may be adjusted based on the results of blood cultures and the specific organism identified. Supportive care, including intravenous fluids, oxygen therapy, and monitoring of vital signs, is also crucial to stabilize the newborn. In severe cases, admission to a neonatal intensive care unit (NICU) may be necessary for close monitoring and advanced supportive measures.

The prognosis for neonatal sepsis depends on several factors, including the timeliness of diagnosis and treatment, the causative organism, and the overall health of the newborn. With prompt and appropriate treatment, many infants recover fully. However, delays in treatment or severe infections can lead to complications such as organ damage, developmental delays, or even death. Early intervention and comprehensive care are key to improving outcomes.

Neonatal sepsis can be caused by a variety of microorganisms, with bacteria being the most common culprits. Group B Streptococcus and Escherichia coli are frequent bacterial causes. Other potential pathogens include Listeria monocytogenes, Staphylococcus aureus, and various viruses and fungi. The infection can be acquired during delivery (early-onset sepsis) or after birth (late-onset sepsis), often through contact with infected individuals or contaminated environments.

Neonatal sepsis is a significant cause of morbidity and mortality worldwide, particularly in low- and middle-income countries. The incidence varies depending on geographic location, healthcare practices, and population demographics. Factors such as premature birth, low birth weight, and maternal infections increase the risk of neonatal sepsis. Efforts to improve prenatal care and infection control measures have contributed to a decline in incidence in some regions.

The pathophysiology of neonatal sepsis involves the invasion of pathogens into the bloodstream, triggering an inflammatory response. This response can lead to widespread tissue damage and organ dysfunction. The immature immune system of newborns makes them particularly vulnerable to infections, as they have limited ability to mount an effective defense. The systemic inflammatory response can result in complications such as septic shock, disseminated intravascular coagulation, and multi-organ failure.

Preventing neonatal sepsis involves a combination of strategies aimed at reducing the risk of infection. Prenatal care is essential, including screening and treatment for maternal infections such as Group B Streptococcus. During delivery, maintaining a sterile environment and minimizing invasive procedures can help prevent early-onset sepsis. Postnatally, promoting breastfeeding, practicing good hygiene, and ensuring timely vaccinations can reduce the risk of late-onset sepsis.

Neonatal sepsis is a serious infection in newborns that requires immediate medical attention. It presents with nonspecific symptoms, making early diagnosis challenging but crucial. The condition is primarily treated with antibiotics and supportive care. While the prognosis can be favorable with prompt treatment, delays can lead to severe complications. Understanding the causes, risk factors, and preventive measures is essential for reducing the incidence and improving outcomes.

If you are a parent or caregiver, it's important to be aware of the signs of neonatal sepsis, which can include fever, difficulty breathing, and poor feeding. If you notice any of these symptoms in your newborn, seek medical attention promptly. Early treatment is vital for the best possible outcome. Preventive measures, such as good prenatal care and hygiene practices, can help reduce the risk of infection.

1. Martius JA, Roos T, Gora B, et al. Risk factors associated with early-onset sepsis in premature infants. Eur J Obstet Gynecol Reprod Biol. 1999;85(2):151–158.
2. Seaward PG, Hannah ME, Myhr TL, et al. International multicenter term PROM study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. Premature Rupture of the Membranes. Am J Obstet Gynecol. 1998 Sep. 179(3 Pt 1):635-639.
3. Romero R, Quintero R, Oyarzun E, et al. Intraamniotic infection and the onset of labor in preterm premature rupture of the membranes. Am J Obstet Gynecol. 1988 Sep;159(3):661-666.
4. Khashu M, Osiovich H, Henry D. Persistent bacteremia and severe thrombocytopenia caused by coagulase-negative Staphylococcus in a neonatal intensive care unit. Pediatrics. 2006 Feb. 117(2):340-348.
5. Engle WD, Rosenfeld CR. Neutropenia in high-risk neonates. J Pediatr. 1984;105(6):982–986.
6. Rodwell RL, Leslie AL, Tudehope DI. Early diagnosis of neonatal sepsis using a hematologic scoring system. J Pediatr. 1988;112(5):761–767.
7. Chan KY, Lam HS, Cheung HM, et al. Rapid identification and differentiation of Gram-negative and Gram-positive bacterial bloodstream infections by quantitative polymerase chain reaction in preterm infants. Crit Care Med. 2009 Aug. 37(8):2441-2447.
8. Vouloumanou EK, Plessa E, Karageorgopoulos DE, Mantadakis E, Falagas ME. Serum procalcitonin as a diagnostic marker for neonatal sepsis: a systematic review and meta-analysis. Intensive Care Med. 2011;37(5):747–762.
9. Philip AG. Response of C-reactive protein in neonatal Group B streptococcal infection. Pediatr Infect Dis. 1985;4(2):145–148.
10. Altunhan H, Annagür A, Örs R, Mehmetoglu I. Procalcitonin measurement at 24 hours of age may be helpful in the prompt diagnosis of early-onset neonatal sepsis. Int J Infect Dis. 2011 Dec. 15(12):e854-458.